Status:
UNKNOWN
Registration Study of Acute Ischemic Stroke/Transient Ischemic Attack (TIA) With Atrial Fibrillation
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Acute Ischemic Stroke
Atrial Fibrillation
Eligibility:
All Genders
18-100 years
Brief Summary
Patient Registration Study of Acute Ischemic Stroke/transient ischemic attack(TIA) With Atrial Fibrillation (AISWAF) is a single-center prospective, consecutively, observational study, was conducted i...
Detailed Description
Patients with acute ischemic stroke (IS) and atrial fibrillation (AF) are at particularly high risk of recurrent IS and other major vascular events. Current antithrombotic therapy guidelines recommend...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years old;
- Acute ischemic stroke or TIA within 14 days of onset (including patients with hemorrhagic transformation of infarction)
- Evidence of atrial fibrillation or newly discovered atrial fibrillation before onset (atrial fibrillation includes valvular and non-valvular, permanent, persistent or paroxysmal);
- Sign informed consent and consent to follow-up for 1 year.
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04080830
Start Date
January 1 2016
End Date
December 30 2021
Last Update
September 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sufang Xue
Beijing, Beijing Municipality, China, 100053